Answers are grounded in this paper and cite their sources.
Objectives: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor deficits, oxidative stress, neuroinflammation, and mitochondrial dysfunction. The present study investigated the neuroprotective effects of Hamamelis virginiana extract against rotenone-induced Parkinson's disease-like pathology in rats. Materials and Methods: Forty adult male Wistar rats were randomly assigned to four groups ( n =10): normal control, H. virginiana extract alone (200 mg/kg, oral), rotenone alone (2 mg/kg, subcutaneous), and combination group (rotenone + extract). Treatments were administered daily for 28 days. Behavioral assessments (open field and forced swim tests) were conducted on day 29. Following euthanasia, brain tissues were collected for biochemical, molecular, and histopathological analyses. Results: Rotenone administration induced significant motor impairment, depressive-like behavior, oxidative stress (elevated malondialdehyde [MDA]; reduced superoxide dismutase [SOD] and catalase [CAT]), neurochemical imbalance (increased acetylcholine, decreased dopamine and tyrosine hydroxylase), neuroinflammation (elevated tumor necrosis factor-alpha [TNF-α] TNF-α, IL-1β, IL-6), and apoptosis (downregulated Bcl-2, upregulated Bax and caspase-3). However, co-administration of H. virginiana extract significantly attenuated these alterations. The extract was associated with elevated levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and HO-1 proteins in brain tissue, restored neurotransmitter balance, suppressed pro-inflammatory cytokines, and promoted anti-apoptotic effects. Furthermore, H. virginiana enhanced mitochondrial quality control by activating the PINK1/Parkin-mediated mitophagy pathway, evidenced by increased PINK1, parkin, and LC3B expression with concurrent p62 reduction. Conclusion: These findings demonstrate that Hamamelis virginiana extract exerts multifaceted neuroprotection against rotenone-induced neurotoxicity through modulation of oxidative stress, inflammation, apoptosis, and mitophagy. Thus, H. virginiana represents a promising therapeutic candidate for Parkinson's disease management.
No takes yet. Share an insight, caveat, or question.
Ahmad Fallata (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: